Equities research analysts predict that Addus HomeCare (NASDAQ:ADUS) will post $0.51 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Addus HomeCare’s earnings, with the lowest EPS estimate coming in at $0.49 and the highest estimate coming in at $0.53. Addus HomeCare posted earnings per share of $0.38 in the same quarter last year, which would suggest a positive year-over-year growth rate of 34.2%. The company is expected to report its next earnings report on Monday, August 6th.
According to Zacks, analysts expect that Addus HomeCare will report full year earnings of $2.21 per share for the current fiscal year, with EPS estimates ranging from $2.14 to $2.28. For the next financial year, analysts forecast that the business will report earnings of $2.63 per share, with EPS estimates ranging from $2.46 to $2.79. Zacks’ earnings per share calculations are an average based on a survey of analysts that that provide coverage for Addus HomeCare.
Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, March 5th. The company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.03. The firm had revenue of $111.96 million for the quarter, compared to the consensus estimate of $110.82 million. Addus HomeCare had a return on equity of 10.04% and a net margin of 3.28%.
Several analysts recently issued reports on the company. ValuEngine raised Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. BidaskClub cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Stephens set a $56.00 target price on Addus HomeCare and gave the stock a “buy” rating in a research note on Monday, April 2nd. Zacks Investment Research raised Addus HomeCare from a “hold” rating to a “strong-buy” rating and set a $60.00 target price on the stock in a research note on Tuesday, May 8th. Finally, Robert W. Baird set a $43.00 target price on Addus HomeCare and gave the stock a “hold” rating in a research note on Wednesday, March 14th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Addus HomeCare has an average rating of “Buy” and an average target price of $51.00.
Addus HomeCare opened at $52.75 on Friday, according to MarketBeat. The stock has a market capitalization of $616.77 million, a PE ratio of 35.17, a P/E/G ratio of 1.77 and a beta of -0.40. The company has a current ratio of 3.01, a quick ratio of 3.01 and a debt-to-equity ratio of 0.22. Addus HomeCare has a 12 month low of $52.55 and a 12 month high of $53.20.
In other Addus HomeCare news, EVP Darby Anderson sold 1,014 shares of Addus HomeCare stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $34.25, for a total transaction of $34,729.50. Following the sale, the executive vice president now directly owns 27,590 shares of the company’s stock, valued at approximately $944,957.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Brian Poff sold 613 shares of Addus HomeCare stock in a transaction that occurred on Thursday, May 10th. The shares were sold at an average price of $52.95, for a total value of $32,458.35. Following the sale, the chief financial officer now directly owns 22,770 shares in the company, valued at $1,205,671.50. The disclosure for this sale can be found here. Insiders sold 6,151 shares of company stock worth $230,678 over the last three months. 35.80% of the stock is owned by insiders.
Institutional investors have recently bought and sold shares of the business. MetLife Investment Advisors LLC bought a new stake in Addus HomeCare during the 4th quarter valued at approximately $146,000. Dorsey & Whitney Trust CO LLC bought a new stake in Addus HomeCare during the 1st quarter valued at approximately $211,000. Connors Investor Services Inc. bought a new stake in Addus HomeCare during the 1st quarter valued at approximately $234,000. Goldman Sachs Group Inc. bought a new stake in Addus HomeCare during the 4th quarter valued at approximately $258,000. Finally, Monarch Partners Asset Management LLC bought a new stake in Addus HomeCare during the 1st quarter valued at approximately $423,000. 59.84% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Get a free copy of the Zacks research report on Addus HomeCare (ADUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.